Daily Vitamin K in Patients on Warfarin With Unstable INRs

Status Completed

Clinical Trial Summary

The purpose of this study is to determine if daily Vitamin K supplementation stabilizes INRs in patients taking warfarin with a history of frequent dose changes or variable INRs.

Clinical Trial Description

Consistent daily Vitamin K intake may contribute to the stabilization of INR values in patients with unstable INRs on warfarin therapy. Subjects with unstable INRs will be identified from the existing patient records of the UNC Anticoagulation Clinics. Eligible subjects will sign an informed consent form and will receive a point-of-care (POC) INR monitoring device. They will undergo 9 weeks of home INR monitoring via the POC device (with monthly clinic follow-up). They will subsequently be provided with 500 mcg Vitamin K tablets to be taken once daily. Weekly POC INR monitoring with monthly clinic follow-up will continue for an additional 8 weeks. ;

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00287313
Study type	Interventional
Source	University of North Carolina, Chapel Hill
Contact
Status	Completed
Phase	N/A
Start date	October 2005
Completion date	May 2006

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT02128841` - Comparison of Antithrombotic Treatments After Aortic Valve Replacement. Rivaroxaban: A New Antithrombotic Treatment for Patients With Mechanical Prosthetic Aortic Heart Valve.	Phase 2
Recruiting	`NCT03666962` - Evaluating Medication Adherence to Novel Oral Anticoagulants With Anticoagulant Activity Monitoring in Patients With Atrial Fibrillation
Recruiting	`NCT03670446` - Pharmacists' Intervention in Patients Using Novel Oral Anticoagulants：A Study on Behavioral Patterns	N/A
Recruiting	`NCT04796714` - AntiPlatelet theraPy stratEgy followiNg Left Atrial appenDAGe closurE	Phase 4
Completed	`NCT01033279` - Quality of Life and Efficacy Evaluation of Patient Self-monitoring Their Oral Anticoagulation Therapy	N/A
Completed	`NCT00222638` - Influenza Vaccination and Oral Anticoagulant Therapy	Phase 4
Active, not recruiting	`NCT06203795` - Dialysis Performance of the FX CorAL Membrane	N/A
Completed	`NCT03864900` - Efficacy of a Health Belief Model Based Intervention for Anticoagulation Adherence	N/A
Active, not recruiting	`NCT06401863` - Shared Decision for Drug Interactions in Oral Anticoagulation	N/A
Not yet recruiting	`NCT04977076` - Comparison Between Direct Oral Anticoagulation (DOAC) Interruption and DOAC Continuation in Patients Undergoing Elective Invasive Coronary Angiography or Percutaneous Coronary Intervention	N/A
Recruiting	`NCT04861103` - Anticoagulation Profile in Pregnant Women Treated With Three Times a Day of Low Molecular Weight Heparin (LMWH)	Phase 4
Completed	`NCT01653405` - Improving Anticoagulation Control in VISN 1	N/A
Not yet recruiting	`NCT05820854` - Self-care and Self-efficacy Scale in Oral Anticoagulation Therapy
Completed	`NCT04681482` - Effectiveness And Safety Of Oral Anticoagulants Among Obese Patients With Non-Valvular A-Fib In VA Patients With Medicare
Not yet recruiting	`NCT06137794` - Application of "I-Anticoagulation"in Patients With Atrial Fibrillation	N/A
Completed	`NCT02103101` - Influence of ABCB1 Polymorphisms on Plasma Concentrations of New Oral Anticoagulants in Case of Serious Adverse Events	N/A
Completed	`NCT05065502` - MIDAS Cluster Randomized Controlled Trial of Implementation Strategies to Optimize Use of Medications in VA Clinical Settings	N/A
Recruiting	`NCT03965208` - Safety and Efficacy of Bivalirudin Versus Heparin for Systemic Anticoagulation in Extracorporeal Membrane Oxygenation	Phase 4
Completed	`NCT03318393` - Study Comparing Bivalirudin Versus Heparin in Neonatal and Pediatric ECMO	Phase 4
Recruiting	`NCT03288441` - Management and Outcomes of Anti-thrombotic Medication Use in Thrombocytopenia